Item

Fractionated radiotherapy for vestibular schwannoma

Wilson, F.
; 
Sahgal, A.
; 
Husain, Z.
; 
Colaco, R.
Citations
Google Scholar:
Lookup
Altmetric:
Abstract
Radiotherapy (RT) has become an increasingly attractive treatment for vestibular schwannomas (VS) in the last 30 years. Fractionated radiotherapy (FRT) for VS typically involves delivering a dose of 2Gy or less daily over the course of several weeks. With increasing advances in linear accelerator technology, it is now possible to deliver FRT with a stereotactic setup (FSRT) to levels of precision previously only seen in patients receiving stereotactic radiosurgery (SRS) with treatments such as Gamma Knife. FRT can be used where patients cannot tolerate SRS, in situations where treatment-related edema might be a concern, and in patients where hearing preservation is paramount. This chapter outlines the delivery of FRT and FSRT together with outcomes and toxicities from fractionated RT treatment in VS.
Authors
Wilson, F.
Sahgal, A.
Husain, Z.
Colaco, R.
Affiliation
Department of Clinical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom. Electronic address: fiona.wilson65@nhs.net. Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Center, Toronto, ON, Canada. Department of Clinical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom.
Description
Date
2025
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Book chapter
Citation
Wilson F, Sahgal A, Husain Z, Colaco R. Fractionated radiotherapy for vestibular schwannoma. Handbook of clinical neurology. 2025;212:277-88. PubMed PMID: 41052850. Epub 2025/10/07. eng.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627760
Embedded videos